Current stock page

Financial Data

DBD Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

TechnologySoftware - ApplicationScore data as of Nov 13, 2026

DBDDiebold Nixdorf, Incorporated

Technology / Software - Application

Low Priority

In Line With Peers

NeutralEdge 4/10
$55.05+$0.30 (+0.55%)

Latest quote

  • Momentum
    33
  • Value
    79
  • Quality
    49
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$994.3M$930.8M$891.8M$1.1B$945.2M$915.2M$841.1M$988.9M
Gross Profit$247.2M$239.6M$225.2M$299.7M$247.9M$242.7M$213.2M$236.4M
Operating Income$38.8M$57.4M$57.8M$127.6M$73.8M$72.6M$47.9M$41.2M
Net Income$6.6M$15.5M$5M$49.6M$41.1M$12.2M-$8.3M$5.6M
EPS$0.2$0.45$0.14$1.39$1.13$0.33-$0.22$0.15
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$47.4M-$20.9M$31.7M$217.5M$37.4M$30.1M$15.7M$196.2M
Capital Expenditure-$12.9M-$7.8M-$5.6M-$14.8M-$12.9M-$17.4M-$9.6M-$10M
Free Cash Flow-$60.3M-$28.7M$26.1M$202.7M$24.5M$12.7M$6.1M$186.2M
Net Cash Provided By Operating Activities-$47.4M-$20.9M$31.7M$217.5M$37.4M$30.1M$15.7M$196.2M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$3.66B$3.74B$3.83B$3.85B$3.72B$3.74B$3.63B$3.54B
Total Debt$1.12B$1.11B$1.09B$1.17B$1.07B$1.06B$1.06B$1.05B
Cash And Cash Equivalents$184.9M$282.4M$373.6M$387.3M$262.6M$279.2M$306.5M$296.2M
Total Liabilities$2.72B$2.76B$2.8B$2.75B$2.61B$2.63B$2.63B$2.61B
Total Stockholders Equity$936.2M$969.2M$1.02B$1.1B$1.11B$1.1B$984M$929.8M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio26.223.8625.4129.0146.87———
P/B ratio2.152.742.682.492.142.031.681.73
P/S ratio0.47———————
Debt To Equity1.21.141.071.070.960.971.071.13
Free Cash Flow Yield6.96%8.46%9.70%8.97%9.68%9.44%10.98%8.64%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio26.223.8625.4129.0146.87———
P/B ratio2.152.742.682.492.142.031.681.73
P/S ratio0.47———————
Return On Equity8.19%11.47%10.55%8.60%4.57%-1.18%-1.04%-1.77%
Debt To Equity1.21.141.071.070.960.971.071.13

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe25.25x
Pb1.98x
Revenue Growth Yoy5.19%
EPS Growth Yoy-82.30%
Gross Margin25.80%
Operating Margin7.18%
ROE7.62%
ROIC7.69%
Debt To Equity1.2
FCF Yield7.56%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$55.05
Volume340,606
RSI (14)34.61
MACD-2.46
MACD signal-2.03
MACD histogram-0.44
ADX (14)36.17
SMA (50)$62.97
SMA (200)$74.34
ATR (14)$2.89
Historical volatility (annualized)61.21%
Volume (20-day average)402,756

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score51/100
Beta1.01
Annual volatility40.65%
Max Drawdown-39.67%
Sharpe Ratio-0.31
VaR (95%, 1-day)-4.11%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

DBD Financial Data FAQ

What is Diebold Nixdorf, Incorporated's revenue?

Diebold Nixdorf, Incorporated's revenue is one of the core financial data points for DBD. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Diebold Nixdorf, Incorporated's revenue growing?

Revenue growth shows whether Diebold Nixdorf, Incorporated is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is DBD's EPS?

DBD's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Diebold Nixdorf, Incorporated's net income?

Diebold Nixdorf, Incorporated's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Diebold Nixdorf, Incorporated generate?

Free cash flow shows how much cash Diebold Nixdorf, Incorporated generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Diebold Nixdorf, Incorporated have?

Cash and debt help frame DBD's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.